[Effects of fosfomycin sodium upon hepatic functions (author's transl)].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000633:toxicity*; D001219:Aspartate Aminotransferases / Q000378:metabolism; D002251:Carbon Tetrachloride / Q000633:toxicity; D004285:Dogs; D004357:Drug Synergism; D005578:Fosfomycin / Q000008:administration & dosage / Q000633:toxicity*; D006160:Guanosine Triphosphate / Q000378:metabolism; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D008297:Male; D008722:Methods; D051379:Mice; D010477:Perfusion; D011817:Rabbits; D051381:Rats
D000900:Anti-Bacterial Agents; D005578:Fosfomycin; D006160:Guanosine Triphosphate; D002251:Carbon Tetrachloride; D001219:Aspartate Aminotransferases